Gentherm Inc (THRM) Stock Analysis

Price updated today · SEC data refreshed 2 months ago · Not investment advice

Gentherm Inc

THRM Consumer Cyclical Motor Vehicles📄 SEC filings ↗ CUSIP 37253A103
Deeply overvalued by model
▾ What's in the 53/100 risk score? (higher = riskier)
Valuation (price vs model IV) (30%) 55/100 → +16.5
Fundamental health (30%) 47/100 → +14.1
leverage 20/100 · FCF trend 90/100 · DCF applicability 30/100 · Altman Z not scored — input unavailable (see Financial Health)
Smart money (short interest + insider buying) (22%) 79/100 → +17.4
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (18%) 28/100 → +5.0
Total53/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend, DCF applicability). It excludes the the Altman Z score, whose retained-earnings input this filer does not report separately, which relies on a proxied (estimated) input. See the Financial Health section for the full balance-sheet read.

💵 Price $44.00 · today 📄 Financials SEC EDGAR · refreshed 2 months ago

How to read THRM

A profitable, cash-generating business — our discounted-cash-flow estimate is the primary lens, cross-checked against what growth the price implies and against peers.

Where to start — the sections that matter most for this stock
  1. 1 The verdict + intrinsic value (our DCF) ↓
    Our estimate of what a share is worth, versus today's price.
  2. 2 Reverse-DCF + the interactive calculator ↓
    See the growth the price assumes, then flex every assumption yourself to pressure-test it.
  3. 3 Football field + peers ↓
    A cross-check across methods and against comparable companies.
Or — what are you trying to decide?
One rule first: never trade out of fear — and that includes the fear of missing out. A stock up 10% a day for three days is excitement, not data. If you can't point to the evidence behind a trade, you're more likely to lose. So whichever of these you are, check the data below before you act.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
⚖️
"Is it worth what it costs?"
The valuation trade. Our DCF, the growth the price implies, and a calculator you drive yourself.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.

Is now a good time to buy THRM?

Macro: Neutral / mid-cycle

THRM trades at $44.00 vs an estimated intrinsic value of $32.52 — a +35.3% premium to model IV. Today's price is consistent with THRM's owner-earnings free cash flow per share growing about 7.9% per year over the next 5 years (the price-implied growth rate). Our DCF projects modeled growth of 8.0% per year based on history + sector defaults (analyst consensus estimates not yet integrated).
Note: this is a 5-year, per-share view. The Reverse-DCF section below asks the same question on a stricter 10-year free-cash-flow?Free Cash Flow (FCF) — Operating cash flow minus capital spending: cash left after a company covers operating costs, taxes and interest and reinvests in the business — but BEFORE repaying debt principal or paying dividends. The cash actually available to investors.
Why it matters: A company can show big profits on paper while burning through cash. FCF is what actually fills the bank account.
Reference: Healthy mature businesses convert 8–15% of revenue into FCF · Growth companies often negative
Full explanation →
basis — so its growth number is different, not contradictory.

▾ Exactly how this 5-year figure is computed
Starting FCF/share: $2.49 (normalized multi-year median)
Current price: $44.00 (live)
Discount rate: 12.1%; terminal growth: 2.5%
Forecast: 5 years explicit growth, then a linear fade to terminal; end-of-period cash flows discounted to today
Growth path: the model's probability-weighted scenarios (conservative 40% / base 35% / optimistic 25%) — see the "Three Scenarios, Weighted" table below for the three IVs
Method: solve for the constant 5-year per-share growth rate that, run through this same structure, makes the intrinsic value equal today's price. (The 10-year figure below uses a flat 10-yr path instead — hence a different number.)

Discount-rate sensitivity: $32.52 – $39.39 (Undervalued → Fairly valued)
12.1% (higher required return) → $32.52 · 10.5% (lower) → $39.39
how is this calculated?
Pegged to beta 1.38 (cost of equity 12.1%); sector/quality cross-check at 10.5%. · 7% small-cap illiquidity discount applied.
Margin of safety
None — price is above our value
Macro regime
Neutral / mid-cycle
No extreme readings in either direction. Stock selection matters more than macro positioning right now.

Not investment advice. The model can be wrong. Verify the assumptions in the sections below and consider consulting a licensed advisor for significant decisions.

ⓘ Why does THRM trade at $44.00?

Gentherm Inc has 30.9 million shares outstanding. At $44.00 per share, the market values all outstanding THRM equity at $1.4 billion. That's market capitalization, not enterprise value — enterprise value also accounts for debt and cash. The share price by itself tells you almost nothing — a company can pick any share price by splitting or issuing more shares. What matters is the total value (Market Cap?Market Cap — The total dollar value the market is assigning to the entire company.
Why it matters: This is the number that actually matters when comparing companies. Two companies with the same business but different share counts have the same market cap.
Reference: Mega cap >$200B · Large $10–200B · Mid $2–10B · Small $300M–2B · Micro <$300M
Full explanation →
) compared to what the business actually produces. This page values THRM in Per Share?Per Share — A company-level figure divided by total shares — what one share represents.
Why it matters: Per-share metrics are the only way to fairly compare two companies with different share counts.
Full explanation →
economics — what each share represents of the underlying business. Play with the share-price calculator on the homepage →

Loading insider & short-seller data…

What cash-flow improvement must the market believe? ?Reverse DCF — Instead of asking "what is this stock worth?", asks "what growth rate is the current market price already assuming?"
Why it matters: It crystallizes the bull thesis as a single number you can argue with. If the market expects 40% growth for 10 years and you do not believe that, the stock is overvalued.
Reference: 10–15% = sustainable for strong companies · 20–25% = exceptional · 30%+ = historically very rare

Reverse DCF treats today's price as correct and solves for the cash-flow path that justifies it. For a cyclical, read the result as the annual improvement in through-cycle free cash flow the price requires — which could come from higher realized commodity prices, margin recovery, lower input costs, more volume, or reduced capex, not just organic growth. The starting base is our normalized mid-cycle median, not last year's number.

To justify today's $44.00 price, THRM's through-cycle free cash flow?Free Cash Flow (FCF) — Operating cash flow minus capital spending: cash left after a company covers operating costs, taxes and interest and reinvests in the business — but BEFORE repaying debt principal or paying dividends. The cash actually available to investors.
Why it matters: A company can show big profits on paper while burning through cash. FCF is what actually fills the bank account.
Reference: Healthy mature businesses convert 8–15% of revenue into FCF · Growth companies often negative
Full explanation →
must improve by:
+9.8%
10-year flat improvement in through-cycle FCF implied by today's price
This is a different figure from the 7.9% in the verdict at the top: that one is the 5-year implied per-share growth on the model's scenario-weighted path, while this is a 10-year flat rate. Different horizon and shape, so a different number — not a contradiction. Both are solved at today's live price.
▾ Exactly how this 10-year figure is computed
Starting FCF/share: $2.49 (normalized multi-year median)
Forecast length: 10 years, single flat growth rate (no fade)
Terminal growth after year 10: 2.5%
Discount rate: 12.1% (the rate the model used)
Price used: $44.00 — the live price shown on this page (not frozen)
Method: solve for the constant annual growth rate that makes the discounted 10-year FCF stream + terminal value equal today's price.
Reasonable

Within range of what a quality mature business can sustainably deliver. Not demanding.

For reference: Reasonable — sustainable for a quality business over time.

▾ How we computed this · Reality check thresholds · Assumptions
Inputs:
  • Starting FCF/share: $2.49 (normalized multi-year median)
  • Discount Rate?Discount Rate — The annual return you demand for taking single-stock risk instead of buying a safe Treasury or index fund.
    Why it matters: Higher discount rate = stricter valuation (a stock has to produce more cash to be worth holding). Lower = more generous.
    Reference: 8–12% is standard · 9–10% matches S&P 500 historical return · Below 7% is illogical for single-stock risk
    Full explanation →
    : 12.1% — standard 8-12%; 9-10% matches S&P 500 historical return
  • Terminal Growth Rate?Terminal Growth Rate — The growth rate we assume the company holds forever, after the explicit 10-year forecast period ends.
    Why it matters: It anchors the long-tail value. Cannot mathematically exceed long-term GDP growth or the company eventually becomes larger than the global economy.
    Reference: 2–3% (matches long-term US GDP growth) · Above 4% is mathematically problematic
    Full explanation →
    : 2.5% — matches long-term GDP growth
  • Forecast horizon: 10 years explicit + terminal perpetuity
Reality-check scale:
≤ 0%Priced for decline — likely undervalued OR dying business
5-12%Reasonable; sustainable for quality businesses
12-18%Demanding — strong execution required
18-25%Exceptional — few companies sustain for a decade
25-35%Heroic — historically very rare
35%+Borderline impossible at scale

Sustaining 30%+ cash-flow growth for a full decade at scale is exceedingly rare — the bar is brutally high.

Use the interactive calculator below to change the discount rate, growth and terminal-growth assumptions and watch the value move.

Football field: where does the price sit?

Different valuation methods produce different fair-value ranges depending on assumptions. Plotting them together lets you see at a glance whether the current price is reasonable across approaches, or only one specific lens.

If FCF grew -5%/yr → 14%/yr (flat 10-yr DCF sweep; model assumes 8.0%)$16$59Our model's scenarios (cons→opt growth, weighted 40/35/25)$28$39Current: $44.00$15$26$38$50$62
Methods disagree: the price is ABOVE 1 of 2 method ranges while inside the rest — assumption-sensitive, not clearly fair.

Industry multiples sourced from: broad market average (sector unknown). See the Peer Basket section below for the peer comparison and its limited-comparables caveat.

How does THRM stack up against its closest peers?

We take the 8 same-industry companies most similar to THRM (similar size) and check what investors are paying for each dollar of their revenue (or profits). If THRM is much more expensive on the same yardstick, that's a red flag — unless you have a specific reason it deserves a premium. For a leveraged business, EV/EBIT and FCF yield (both in the table) are usually more reliable than EV/Sales, because revenue multiples ignore differences in margins and debt.

▾ What's "EV / Sales" in plain English?

EV (Enterprise Value) = market cap + total debt − cash. It's "what you'd pay to buy the entire company outright" — you pay the market cap to shareholders and take over their debt, but you keep their cash. EV is fairer than market cap alone because it includes the debt the new owner inherits.

EV / Sales = EV ÷ annual revenue. So "2.5×" means investors pay $2.50 of enterprise value per $1 of yearly sales. Higher = market is paying more per dollar of sales (usually because they expect future growth or fat margins).

p25 / median / p75 are the 25th, 50th (middle), and 75th percentile of the peers' multiples. Half the peers fall between p25 and p75. The median (p50) is the typical peer — that's the benchmark we compare to.

What peers trade at (p25 / median / p75)
EV / Sales?EV / Sales — For every $1 of yearly revenue, this is how many dollars investors pay to own the whole business (including debt).
Why it matters: Works for pre-profit growth companies where P/E and FCF don't apply. The most apples-to-apples cross-company multiple because it ignores accounting choices.
Reference: 1–3x for mature companies · 4–10x for software/SaaS · 10–20x for hypergrowth · >20x is rare and demanding
Full explanation →
0.5x / 0.9x / 1.0x
EV / Gross Profit?EV / Gross Profit — Enterprise value divided by gross profit — the multiple paid for what each dollar of sales contributes after direct costs.
Why it matters: More refined than EV/Sales for high-margin businesses (software, marketplaces) where gross margin is the real economic engine.
Reference: 8–15x for SaaS · 15–25x for hypergrowth software · >30x demanding
Full explanation →
2.7x / 3.7x / 7.3x
EV / EBIT?EV / EBITDA — Enterprise value divided by earnings before interest, tax, depreciation, and amortization.
Why it matters: A classic "what would a private buyer pay" multiple — used in M&A. Strips out tax and capital-structure noise.
Reference: 8–12x for mature businesses · 15–25x for growth · Below 5x often signals distress
Full explanation →
12.8x / 13.3x / 24.1x

Bold middle number = median peer. Half the peers trade above it, half below. Computed over 8 same-industry peers; implausible multiples excluded.

What THRM would be worth at the median peer's multiple
$40.37
If THRM traded at the typical (median) peer's EV/Sales multiple, the share price would be about $40.37.
Plain English: the stock currently trades at $44.00. That's 9.0% above what peer multiples imply — modest premium, probably justifiable if fundamentals are slightly better than peers.

⚠️ Important caveat: peer multiples only work if the peers are genuinely comparable. Always check the peer list below — if the auto-picker grabbed micro-caps or unrelated businesses, the comparison is noise. A medical-device giant priced against tiny biotech startups won't produce a useful signal.

▾ View peer list (8)
Ticker Company Industry Mcap EV/Sales EV/GP EV/EBIT FCF Yield
HYLN Hyliion Holdings Corp. Motor Vehicles $1.2B 358.7x 7,332.4x 0.1%
DCH Dauch Corp Motor Vehicles $1.6B 1.0x 8.0x 50.0x 32.3%
AEVA Aeva Technologies, Inc. Motor Vehicles $1.8B 98.3x 0.0%
ADNT Adient plc Motor Vehicles $1.8B 0.1x 1.9x 10.4%
SMP STANDARD MOTOR PRODUCTS, INC. Motor Vehicles $872M 0.8x 2.7x 10.9x 5.5%
BLBD Blue Bird Corp Motor Vehicles $2.1B 1.5x 7.3x 13.3x 4.1%
WGO WINNEBAGO INDUSTRIES INC Motor Vehicles $839M 0.5x 3.8x 24.1x 22.6%
LCII LCI INDUSTRIES Motor Vehicles $2.6B 0.9x 3.7x 12.8x 10.9%

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
n/a
Not reliably computable

We can't produce a trustworthy Altman Z here: retained earnings weren't separately reported in our data, so a core input would have to be fabricated. Rather than show a categorical "distress" verdict from an invented number, we mark it unavailable. Judge financial health from the leverage, cash position, and the measurable Piotroski checks instead.

Read with caution for this industry. Automakers (and airlines) run a large captive finance arm, which inflates total assets and liabilities and depresses Altman Z — it routinely reads "distress" even for investment-grade names with full access to capital markets. Treat it as one input, not a literal bankruptcy probability. Weigh it against the company's cash position, near-term debt maturities, and where it sits in the economic cycle.

Piotroski F-Score?Piotroski F-Score — A 9-point quality checklist scoring profitability, leverage, and operating efficiency.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
5 / 9
Mediocre
▾ The checks — what passed, what didn't (and what we couldn't measure)
  • Positive net income
    Net income $18.3M in the latest year.
  • Positive operating cash flow
    Operating cash flow $116.8M (was $109.6M the prior year).
  • Cash flow backs up reported profit
    Operating cash flow $116.8M vs net income $18.3M.
  • Return on assets improving
    Return on assets 1.3% vs 5.2% a year ago.
    Why this matters: Is the company squeezing more profit out of each dollar of assets than last year? Rising = getting more efficient; falling = the opposite.
  • Debt load (vs assets)
    Long-term debt is 13.5% of assets vs 17.7% a year ago ($189.1M now).
  • Short-term liquidity (current ratio)
    Current ratio 1.92x vs 2.01x a year ago.
    Why this matters: The current ratio compares assets it can turn to cash within a year against bills due within a year. Below 1.0 means it may struggle to cover near-term obligations.
  • Share count (dilution)
    Share count declined 1.7% (31.5M → 30.9M year-over-year), so the no-dilution check passed. (This 1-year change differs from the ~4%/yr multi-year buyback CAGR the DCF cites.)
  • Pricing power (gross margin)
    Gross margin 24.2% vs 25.2% a year ago.
    Why this matters: Rising gross margin means stronger pricing power or lower input costs — a sign of competitive strength. Falling margin signals pressure.
  • Sales per asset (asset turnover)
    Asset turnover 1.07x vs 1.17x a year ago.
    Why this matters: Asset turnover measures how much revenue each dollar of assets generates. Rising = more productive use of the asset base.

Missing data is never counted as a pass or a fail — it's shown as n/a and excluded from the denominator. Each check compares the company against its own prior year.

What if you assume different inputs?

Here's where we land — and what happens if you change the assumptions. Drag the sliders to set your own Discount Rate?Discount Rate — The annual return you demand for taking single-stock risk instead of buying a safe Treasury or index fund.
Why it matters: Higher discount rate = stricter valuation (a stock has to produce more cash to be worth holding). Lower = more generous.
Reference: 8–12% is standard · 9–10% matches S&P 500 historical return · Below 7% is illogical for single-stock risk
Full explanation →
(the annual return you demand for single-stock risk) and terminal growth; the value updates live so you can see whether the stock looks cheaper or richer. The discount rate starts at 12.1%, the figure our model used for THRM. Open Advanced to also change beta, growth and the rate path.

Note: at default inputs this calculator mirrors the headline model's three-scenario weighting (conservative/base/optimistic, 40/35/25), so its opening value should land close to the headline intrinsic value of $32.52. A small gap is rounding; a large one would be a data problem — and we check for it below.

Probability-weighted model IV
$32.52
It trades at
$44.00
Premium to model IV
+35.3%
Price is 35% above model IV — it looks overvalued. Change the assumptions below to see what would justify today's price.
We value this stock at two discount rates and report the range between them:
12.1% — beta-based (CAPM), from this stock's Beta?Beta — How much the stock moves when the overall market moves. 1.0 = moves with the market; 1.5 = moves 50% more than the market.
Why it matters: Higher beta = more volatile = should demand higher discount rate. Low beta stocks (utilities, consumer staples) move less.
Reference: Most stocks 0.5–1.5 · Defensives ~0.3 · High-vol tech ~1.5–2.0
Full explanation →
of 1.38.
The safe Treasury rate plus a premium scaled by how much more (or less) volatile the stock is than the market.
10.5% — sector/quality tier. A simpler hurdle set by industry and business durability: lower for stable, wide-moat companies; higher for speculative or micro-caps.
The headline value and this calculator start at 12.1% — the beta-based rate. Drag the slider to the other rate to see the full range.
4.5% (risk-free)9-10% normal18% (deep-risk)
0%2-3% (GDP)5% (rarely sustainable)
Flat-path value at your assumptions (single growth path — not the probability-weighted scenario IV)
$32.52
vs today's $44.00
+35.3%

At the default assumptions the flat path lands near our published value of $32.52. Move any slider to recompute it with your own.

For comparison — the FCF growth today's price already assumes

⚙ Advanced — tinker with every input (beta, growth, rate path, margin → full intrinsic value)
Where the discount rate comes from — discount rate = risk-free + beta × equity-risk-premium
What you'd earn risk-free from government bonds — the floor under every other rate. Slide it down to model the market expecting rate cuts (value rises); up for higher-for-longer.
The extra yearly return investors demand for owning stocks instead of safe bonds — the price of risk. History runs ~4.5–6.5%; we default to 5.5% (slightly conservative). It's an estimate, not a law — lower it if you think equities are less risky than that.
Inflation quietly eats returns: a 9% gain at 3% inflation is only ~6% in real purchasing power. The intrinsic value above is already in today's dollars (a nominal DCF cancels inflation out of both growth and the discount rate), so this doesn't change the value — it shows what's left of your return after the tax.
Higher beta → higher discount rate (sets the rate above). 1.0 = moves with the market.
What you think THRM can grow FCF for ~5 years, then fades to terminal.
All inputs start at the values our model used.

    Copy shareable link to this scenario →

    Price$44.00
    Model IV$32.52
    Premium to IV+35.3%
    DCF applicabilityHigh
    Implied Growth (5-yr)7.9%
    Return to IV (3yr, annualized)-9.6%
    To justify $44, THRM needs ~7.9% annual growth for 5 years — vs the model's 8.0%.

    Gentherm Inc (THRM) trades at a premium of +6.7% to its intrinsic value?Intrinsic Value — Our DCF model's estimate of what each share is mathematically worth based on projected cash flows.
    Why it matters: Compare to current price. Below IV = potentially undervalued. Above IV = priced for growth that must actually happen.
    Reference: Model-derived; quality depends on data and assumptions.
    Full explanation →
    , with the market likely paying for its consistent revenue growth of 9.4%/yr over four years and its positive net income and operating cash flow for five consecutive years. The market appears optimistic about its ability to maintain profitability despite compressing gross margins. The number one quantifiable risk is the rising long-term debt, which has increased from $39M to $189M.

    ⚠️ Cyclical sector: using normalized cash flow (median OCF minus estimated maintenance capex).

    As of 2 months ago

    Anatomy of a share

    What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

    THRM Gentherm Inc stock anatomy showing per-share revenue, operating expenses, free cash flow, and debt
    1.2%
    profit
    Where each $1 of revenue goes
    Net profit — 1.2¢ of every dollar ($0.59/sh — latest fiscal-year net income per share)
    Costs & taxes — 98.8¢ (on $48.45 revenue/sh)
    Net margin = net income ÷ revenue (most recent fiscal year).
    Plain English: $44/share buys $48.45 of revenue per share per year, generates $0.59 of net income per current share, and $1.58 of owner-earnings free cash flow per current share (latest fiscal year). Each share carries $6.11 of debt. The DCF does not start from that single year — it instead starts from a normalized multi-year median of $2.49 per share to capture a full cycle.
    What's free cash flow / what do these mean?

    Revenue per share — how much the business earns from customers, divided by the number of shares outstanding. Top of the income statement.

    Earnings per share — profit left after operating costs, interest, and taxes, per share. Two versions appear on this page and are not interchangeable: GAAP diluted EPS uses the company's weighted-average diluted share count during the reporting period (this is the "earnings" in "price-to-earnings"); net income per current share divides annual net income by today's share count. They differ whenever the share count has changed.

    Owner-earnings free cash flow per share — the cash the business produces for shareholders. Savng's owner-earnings FCF subtracts capital expenditures and stock-based compensation from operating cash flow (SBC is a real dilution cost even though it's non-cash). This is deliberately more conservative than "standard" FCF, which subtracts only capital expenditures — so our figure is lower than the headline FCF you'll see elsewhere. FCF funds dividends, buybacks, debt repayment, and acquisitions; a company can report positive earnings yet negative FCF.

    Debt per share — total interest-bearing borrowings divided by shares. High debt-per-share next to thin FCF-per-share is a fragility signal.

    What you actually need to decide

    Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

    🐂 The Bull Case
    For the stock to perform, THRM must continue its revenue growth trajectory and demonstrate its ability to expand into new markets beyond automotive, leveraging its core thermal technologies.
    🐻 The Bear Case
    The biggest fundamental risk is the compressing gross margin (29% to 24.2%), which, if it continues, could erode profitability despite revenue growth and impact future free cash flow?Free Cash Flow (FCF) — Operating cash flow minus capital spending: cash left after a company covers operating costs, taxes and interest and reinvests in the business — but BEFORE repaying debt principal or paying dividends. The cash actually available to investors.
    Why it matters: A company can show big profits on paper while burning through cash. FCF is what actually fills the bank account.
    Reference: Healthy mature businesses convert 8–15% of revenue into FCF · Growth companies often negative
    Full explanation →
    generation.
    📌 Signposts to watch — update your view as these print
    • Gross margin stabilization or improvement in future quarters
    • Continued revenue growth rates above 9%
    • Management commentary on debt reduction strategies

    The trend, in plain numbers (2024 → 2025)

    Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.

    ✅ Improving
    • Revenue grew +3% to $1.50B.
    • Free cash flow rose to $48.8M.
    ⚠ Worsening
    • Gross margin shrank to 24% (-1 pts).
    • Net income fell -72% to $18.3M.

    Management & Leadership

    Gentherm Inc. is led by President and CEO Phil E. Eyler, who has been in his role since 2017. He has focused on expanding the company's thermal management and comfort technologies across various industries. The executive team also includes Matteo Anversa as CFO.

    Phil E. Eyler
    President and Chief Executive Officer
    Matteo Anversa
    Chief Financial Officer

    What They Make

    Gentherm designs, develops, and manufactures innovative thermal management technologies. Their products primarily serve the automotive industry, providing heated and cooled seating, steering wheel heaters, and other climate control solutions.

    End Markets

    Automotive (OEMs)Medical (patient temperature management)Consumer (specialty applications)

    Revenue Drivers

    Automotive comfort systems
    Battery thermal management
    Medical patient temperature management
    Market Cap: 1.4BBeta: 1.38

    Why Is It Priced Like This?

    Why Customers Pay

    Enhanced passenger comfort and safety
    Improved battery performance and longevity
    Precise temperature control for medical applications
    Intrinsic Value$32.52
    Premium to IV +35.3%
    Implied Growth (5-yr)7.9% Market prices 7.9% growth. Model: 8.0%.
    Return to IV (3yr, annualized) -9.6%

    The market prices THRM at a premium of +6.7% to the model, likely due to its consistent revenue growth of 9.4%/yr over four years and its track record of positive net income and operating cash flow for five consecutive years. These health signals suggest a durable business, despite the gross margin compressing from 29% to 24.2%, which the market seems to overlook in favor of top-line expansion and profitability.

    Three Scenarios, Weighted
    ScenarioIVvs PriceWeight
    Conservative$28.24-35.8%40%
    Base$33.05-24.9%35%
    Optimistic$38.63-12.2%25%
    Weighted$32.52-26.1%100%

    What has to be true (historical comparison)

    To justify today's price, THRM's owner-earnings cash flow must grow to roughly 1.5× its current level over 5 years. If profit margins and share count stay roughly constant, that is equivalent to about the same multiple of revenue. Each card below is a real company that grew revenue at a comparable magnitude — possibly in a different industry; the point is the growth magnitude required and its historical base rate, not that THRM resembles these businesses. The green/amber line shows whether that company cleared or fell short of the bar, and the tag on the right shows how it actually fared afterward (succeeded, faded, or wiped out).

    Amazon FY1999 ✓ went on to succeed
    4.1× revenue in 5 years
    Cleared the ~1.5× THRM needs

    Lost $720M on $1.6B revenue. The market priced in dominance of online retail. Took 9 years for the share price to make a new high but ultimately compounded 170x in revenue.

    Tesla FY2018 ✓ went on to succeed
    4.5× revenue in 5 years
    Cleared the ~1.5× THRM needs

    Still losing money producing Model 3 at scale. Vehicle margins were below 20%. Stock 15x'd over the next four years as margins crossed into autos' best-in-class range.

    IBM FY1999 ✗ stalled out
    1.4× revenue in 5 years
    Fell short of the ~1.5× THRM needs

    What 'scale' looked like in 1999 for comparison purposes. Big and profitable. Revenue actually declined over the next 20 years.

    Anchors are hand-curated 10-K snapshots. We surface the three whose 5-year revenue growth most-closely brackets the rate required to justify the current price. Source: SEC EDGAR.

    Business Model & Valuation

    How They Make Money

    Sales of automotive thermal comfort systems to OEMs
    Sales of battery thermal management systems
    Sales of medical patient temperature management systems

    The company funds itself through its positive operating cash flow, which has been positive for five consecutive years, and has seen its long-term debt rising from $39M to $189M.

    Normalized FCF High

    Cyclical/commodity sector (Motor Vehicles): normalized FCF uses 5-year median to smooth peak/trough distortions.

    In plain English: we estimate THRM's value by projecting its owner-earnings free cash flow (operating cash flow minus capital expenditure and stock-based compensation) into the future and converting it back to what it's worth today. We start from $2.49 per share (normalized multi-year median), assume it grows 8.0% per year for about 5 years (then gradually fades), and discount everything at 12.1% — the yearly return a buyer should demand for this much risk. After that it's assumed to grow 2.5% per year forever (roughly the long-run pace of the whole economy). A higher discount rate or slower growth means a lower value, and vice-versa — change any of these yourself in the calculator above.
    Owner-earnings FCF / share$2.49normalized multi-year median — smoothed, not the latest single year
    Growth (g₁) — 5yr8.0%Source: blend(70% revenue cagr, 30% sector)
    Discount Rate (r)12.1%
    Terminal Growth (gT)2.5%
    Show advanced inputs
    RevenueGrowth9.4%
    EpsGrowth-32.1%
    HistoricalFcfGrowth-18.5%
    SectorDefault8.0%
    BestEstimate9.0%
    Methodblend(70% revenue_cagr, 30% sector)
    GrowthBasistotal

    What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project its revenue segments independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

    Maturity & Competitive Position

    Mature compounder

    Moat Signals

    Proprietary thermal technology patents
    Deep integration with automotive OEM supply chains
    Specialized expertise in thermal management solutions

    Revenue has grown at 9.4%/yr over four years, increasing from $1046M to $1499M.

    Geography & Markets

    Gentherm is headquartered in the US and operates globally, with significant presence in North America, Europe, and Asia to serve its diverse automotive and medical customer base. Specific geographic revenue percentages are not available from current data sources.

    Geographic Risks

    Concentration risk within the automotive industry, making it susceptible to cyclical downturns in vehicle production.
    Rising long-term debt, which has increased from $39M to $189M, could strain financial flexibility.

    Market Signals

    These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

    Model neutral, tape neutral - aligned.
    RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
    Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
    Reference: 30–70 normal · >70 overbought · <30 oversold
    Full explanation →
    (14)
    70.7OverboughtBought up hard recently — stretched; pullbacks are common from here.
    MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
    Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
    Reference: Line above signal = bullish momentum · below = bearish
    Full explanation →
    BullishLine above signalThe fast trend is above the slow trend — short-term momentum is currently upward.
    50-Day Average$29.91Price above (+47.1%)Price above its 50-day average = near-term uptrend.
    200-Day Average$33.75Price aboveThe 200-day line is the long-term trend divider — above it is generally considered a bull market for the stock.
    50 vs 200 CrossDeath50-day below 200-dayA "death cross" — the medium trend is below the long trend (often read as bearish).

    Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

    Data Quality & Risk Flags (3 notes — click to expand/collapse)

    Guardrail Notes (3)
    • Cyclical sector: using normalized cash flow (median OCF minus estimated maintenance capex).
    • Median OCF: $116.79M, est. maintenance capex: $39.70M, normalized FCF: $77.09M.
    • Illiquidity discount 7% applied (small/micro-cap — harder to exit, demand a margin).

    Financial Statements (5-year tables — click to expand)

    From Gentherm Inc's SEC filings (EDGAR).

    Income (5yr)

    YearRevenueNet IncomeEPS
    20251.5B18.3M$0.59
    20241.5B64.9M$2.06
    20231.5B40.3M$1.22
    20221.2B24.4M$0.73
    20211.0B93.4M$2.79

    Cash Flow (5yr)

    YearOperating CFCapEx− SBC & adj.Free Cash Flow
    2025 116.8M 55.7M 12.3M 48.8M
    2024 109.6M 73.3M 10.4M 25.9M
    2023 119.3M 37.6M 11.6M 70.0M
    2022 14.9M 39.7M 6.6M -31.4M
    2021 143.1M 38.5M 14.5M 90.1M

    How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). Latest year: 116.8M − 55.7M − 12.3M (SBC & adj.) = 48.8M. This is the same owner-earnings FCF definition the valuation model uses, though the DCF's starting value is a normalized multi-year median, not this single year.

    Balance Sheet

    Total Assets1.4B
    Total Liabilities676.1M
    Equity720.3M
    Total Debt189.1M

    Similar companies worth a look

    Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.

    PG
    Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
    ⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
    🔔 Follow $THRM — free insider alerts
    One email when an insider buys $THRM on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.